| The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers DA Russler-Germain, DH Spencer, MA Young, TL Lamprecht, CA Miller, ... Cancer cell 25 (4), 442-454, 2014 | 451 | 2014 |
| CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression DH Spencer, DA Russler-Germain, S Ketkar, NM Helton, TL Lamprecht, ... Cell 168 (5), 801-816. e13, 2017 | 222 | 2017 |
| Microtubules provide directional information for core PCP function M Matis, DA Russler-Germain, Q Hu, CJ Tomlin, JD Axelrod Elife 3, e02893, 2014 | 123 | 2014 |
| Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies CB Cole, DA Russler-Germain, S Ketkar, AM Verdoni, AM Smith, ... The Journal of clinical investigation 127 (10), 3657-3674, 2017 | 91 | 2017 |
| Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant JJ Bednarski, C Zimmerman, MM Berrien-Elliott, JA Foltz, ... Blood, The Journal of the American Society of Hematology 139 (11), 1670-1683, 2022 | 69 | 2022 |
| Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism P Zhang, W Land, S Lee, J Juliani, J Lefman, SR Smith, D Germain, ... Journal of structural biology 150 (2), 144-153, 2005 | 68 | 2005 |
| Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia MM Berrien-Elliott, JA Foltz, DA Russler-Germain, CC Neal, J Tran, ... Science translational medicine 14 (633), eabm1375, 2022 | 57 | 2022 |
| PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia CB Cole, AM Verdoni, S Ketkar, ER Leight, DA Russler-Germain, ... The Journal of clinical investigation 126 (1), 85-98, 2016 | 43 | 2016 |
| Memory-like differentiation enhances NK cell responses to melanoma ND Marin, BA Krasnick, M Becker-Hapak, L Conant, SP Goedegebuure, ... Clinical Cancer Research 27 (17), 4859-4869, 2021 | 40 | 2021 |
| A fusion protein complex that combines IL-12, IL-15, and IL-18 signaling to induce memory-like NK cells for cancer immunotherapy MK Becker-Hapak, N Shrestha, E McClain, MJ Dee, P Chaturvedi, ... Cancer immunology research 9 (9), 1071-1087, 2021 | 39 | 2021 |
| high cost of chimeric antigen receptor T-cells: challenges and solutions ERS Cliff, AH Kelkar, DA Russler-Germain, FA Tessema, AJN Raymakers, ... American Society of Clinical Oncology Educational Book 43, e397912, 2023 | 14 | 2023 |
| Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation AD Richarson, DA Scott, O Zagnitko, P Aza-Blanc, CC Chang, ... Elife 5, 474-478, 2016 | 13 | 2016 |
| T-BET and EOMES sustain mature human NK cell identity and antitumor function P Wong, JA Foltz, L Chang, CC Neal, T Yao, CC Cubitt, J Tran, ... The Journal of Clinical Investigation 133 (13), 2023 | 9 | 2023 |
| Idecabtagene vicleucel: questions regarding the appropriate role and cost K Powell, D Russler‐Germain, V Prasad British Journal of Haematology 196 (2), e15-e16, 2022 | 5 | 2022 |
| Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical SCT with post-transplant cyclophosphamide L Eastburg, DA Russler-Germain, R Abboud, P Westervelt, JF DiPersio, ... Blood 134, 4496, 2019 | 5 | 2019 |
| Ultra-deep sequencing reveals the mutational landscape of classical Hodgkin lymphoma F Gomez, B Fisk, JF McMichael, M Mosior, JA Foltz, ZL Skidmore, ... Cancer Research Communications 3 (11), 2312-2330, 2023 | 4 | 2023 |
| Frontline polatuzumab vedotin for diffuse large B‐cell lymphoma: A survey of clinician impressions A Major, ERS Cliff, DA Ermann, U Durani, DA Russler‐Germain EJHaem 3 (3), 930-935, 2022 | 4 | 2022 |
| A template-propagation method for segmentation of filamentous structures in electron tomograms W Shen, P Zhang, D Germain, T Rouault, S Subramaniam 2004 2nd IEEE International Symposium on Biomedical Imaging: Nano to Macro …, 2004 | 4 | 2004 |
| Cell-of-origin effect of polatuzumab vedotin in diffuse large B-cell lymphoma: no ordinary subgroup analysis DA Russler-Germain, ERS Cliff, NL Bartlett Blood 142 (25), 2216-2219, 2023 | 3 | 2023 |
| Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303 DA Russler-Germain, K Krysiak, C Ramirez, M Mosior, MP Watkins, ... Blood advances 7 (18), 5524-5539, 2023 | 3 | 2023 |
